Th2 lymphocyte clone can activate macrophage antileishmanial defense by a lymphokine-independent mechanism in vitro and can augment parasite attrition in vivo

This publication has 18 references indexed in Scilit:

• A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
  The Journal of Experimental Medicine, 1990
• Macrophage activation by interferon‐γ from host‐protective T cells is inhibited by interleukin (IL) 3 and IL 4 produced by disease‐promoting T cells in leishmaniasis
  European Journal of Immunology, 1989
• T-Cell Responses and Immunity to Experimental Infection with Leishmania Major
  Annual Review of Immunology, 1989
• Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
  The Journal of Experimental Medicine, 1989
• Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.
  The Journal of Experimental Medicine, 1988
• Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.
  The Journal of Experimental Medicine, 1987
• The Purification and Characterization of Rat Gamma Interferon by Use of Two Monoclonal Antibodies
  Journal of General Virology, 1986
• THE ENHANCEMENT OF MACROPHAGE BACTERIOSTASIS BY PRODUCTS OF ACTIVATED LYMPHOCYTES
  The Journal of Experimental Medicine, 1973
• Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes
  Cellular Immunology, 1972
• THE INFLUENCE OF IMMUNOLOGICALLY COMMITTED LYMPHOID CELLS ON MACROPHAGE ACTIVITY IN VIVO
  The Journal of Experimental Medicine, 1969